Trials / Completed
CompletedNCT02215694
Supplementation of Dual Probiotic Strains Reduced Fasting Triglyceride and Enhanced Apolipoprotein A-V Levels
Supplementation of Dual Probiotic Strains, Lactobacillus Curvatus HY7601 and Lactobacillus Plantarum KY1032, Reduced Fasting Triglyceride and Enhanced Apolipoprotein A-V Levels in Nondiabetic and Hypertriglyceridemic Subjects
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 128 (actual)
- Sponsor
- Yonsei University · Academic / Other
- Sex
- All
- Age
- 24 Years – 68 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effect of dual probiotic strains containing Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 on triglyceride and apolipoprotein A-V.
Detailed description
A randomized, double-blind, placebo-controlled study was conducted on 128 nondiabetic and hypertriglyceridemic (Plasma Triglyceride, 150-500 mg/dL) subjects. Over a 12 week test period, the probiotic group consumed 2g of powder daily containing dual probiotic strains, while the placebo group consumed the same without probiotics.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | dual probiotics | 2g of powder daily containing dual probiotics(Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032) |
| DIETARY_SUPPLEMENT | placebo | 2g of powder daily without probiotics |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2014-03-01
- Completion
- 2014-03-01
- First posted
- 2014-08-13
- Last updated
- 2014-08-13
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02215694. Inclusion in this directory is not an endorsement.